174 related articles for article (PubMed ID: 36657633)
1. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT
Perez-Garcia G; Bicak M; Haure-Mirande JV; Perez GM; Otero-Pagan A; Gama Sosa MA; De Gasperi R; Sano M; Barlow C; Gage FH; Readhead B; Ehrlich ME; Gandy S; Elder GA
Neurosci Lett; 2023 Feb; 797():137080. PubMed ID: 36657633
[TBL] [Abstract][Full Text] [Related]
2. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
Ahmad F; Mein H; Jing Y; Zhang H; Liu P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
5. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy.
Choi YB; Dunn-Meynell AA; Marchese M; Blumberg BM; Gaindh D; Dowling PC; Lu W
Alzheimers Res Ther; 2021 Jan; 13(1):32. PubMed ID: 33504364
[TBL] [Abstract][Full Text] [Related]
7. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
8. Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APP
Briggs DI; Defensor E; Memar Ardestani P; Yi B; Halpain M; Seabrook G; Shamloo M
eNeuro; 2017; 4(4):. PubMed ID: 28721361
[TBL] [Abstract][Full Text] [Related]
9. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
10. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.
Carroll JC; Iba M; Bangasser DA; Valentino RJ; James MJ; Brunden KR; Lee VM; Trojanowski JQ
J Neurosci; 2011 Oct; 31(40):14436-49. PubMed ID: 21976528
[TBL] [Abstract][Full Text] [Related]
11. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.
Melis V; Zabke C; Stamer K; Magbagbeolu M; Schwab K; Marschall P; Veh RW; Bachmann S; Deiana S; Moreau PH; Davidson K; Harrington KA; Rickard JE; Horsley D; Garman R; Mazurkiewicz M; Niewiadomska G; Wischik CM; Harrington CR; Riedel G; Theuring F
Cell Mol Life Sci; 2015 Jun; 72(11):2199-222. PubMed ID: 25523019
[TBL] [Abstract][Full Text] [Related]
12. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
13. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
Parra Bravo C; Krukowski K; Barker S; Wang C; Li Y; Fan L; Vázquez-Rosa E; Shin MK; Wong MY; McCullough LD; Kitagawa RS; Choi HA; Cacace A; Sinha SC; Pieper AA; Rosi S; Chen X; Gan L
Mol Neurodegener; 2024 Jun; 19(1):51. PubMed ID: 38915105
[TBL] [Abstract][Full Text] [Related]
14. β-amyloid accumulation enhances microtubule associated protein tau pathology in an APP
Jiang L; Roberts R; Wong M; Zhang L; Webber CJ; Libera J; Wang Z; Kilci A; Jenkins M; Ortiz AR; Dorrian L; Sun J; Sun G; Rashad S; Kornbrek C; Daley SA; Dedon PC; Nguyen B; Xia W; Saito T; Saido TC; Wolozin B
Front Neurosci; 2024; 18():1372297. PubMed ID: 38572146
[TBL] [Abstract][Full Text] [Related]
15. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.
Woerman AL; Patel S; Kazmi SA; Oehler A; Freyman Y; Espiritu L; Cotter R; Castaneda JA; Olson SH; Prusiner SB
JAMA Neurol; 2017 Dec; 74(12):1464-1472. PubMed ID: 29059326
[TBL] [Abstract][Full Text] [Related]
18. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M
Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390
[TBL] [Abstract][Full Text] [Related]
19. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
20. Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy.
Lyons CE; Graves SI; Razzoli M; Jeganathan K; Mansk RP; McGonigle S; Sabarinathan N; van Deursen JM; Baker DJ; Bartolomucci A
Psychosom Med; 2024 Jun; 86(5):366-378. PubMed ID: 37910129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
